This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Killer cells

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • cells of the inate immune system
  • are mononuclear and have lymphocyte morphology
    • their different surface characteristics however prevent them from being classified as either B or T cells.
  • also known as “large granular lymphocytes” (LGLs)
  • mainly found in the circulation
  • comprise between 5-11% of the total lymphocyte fraction
  • possess receptors for immunoglobulin type G (IgG)
  • also contain two unique cell surface receptors known as killer activation receptor and killer inhibition receptor
    • activation of killer activation receptor initiates cytokine (“communication”) molecules from the cell
    • activation of the killer inhibition receptor inhibits the cytokines
  • have an important role in attacking virally-infected cells in addition to certain tumour cells
  • destruction of infected cells is achieved through the release of perforins and granyzymes from its granules, which induce apoptosis (programmed cell death)
  • able to secrete interferon-alpha
    • interferon alpha prevents healthy host cells from becoming infected by a virus; and augments the T cell response to other virally infected cells
  • cells lyse antibody-coated cells in the absence of complement by attaching to the Fc potion of the antibody molecule

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.